Cefazolin in Dextrose Injection
Baxter recalls Cefazolin in Dextrose 2g/100mL infusion bags due to particulate matter.
Do not use the recalled product. Quarantine any affected units and return them to Baxter Healthcare Corporation. Contact Baxter at 1-800-422-9837 for instructions on returning the product and to arrange for replacement.
Recall at a glance
- Quantity recalled
- 19,032 bags
Why it was recalled
Baxter Healthcare is recalling Cefazolin in Dextrose Injection, USP, 2g/100mL (20mg/mL) single-dose infusion bags due to the presence of particulate matter, which could cause serious adverse health consequences if administered.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
2G3508
- Lot code
- LD175708
- Best-by
- 14-Feb-2027
- NDC
- 0338-3508-41
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Foreign Material recalls
Other recent recalls from Baxter Healthcare Corporation
Sources
Press releases
Editorial summary by Recall Canary · summary updated 2026-08-23 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification